logo
Select company
Select metric
$ 1.55MEarning Before Interest & Taxes (EBIT)
VS
Market
42
Sector
78
Industry
91
History
100
$ 1.29Close
$ 1.06 - $ 2.55 52-Week Range
Ticker Information

Ticker

HRTX

Company Name

HERON THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

HERON THERAPEUTICS INC - Earning Before Interest & Taxes (EBIT) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

HRTX - EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)
6/30/2025$ 1.55M
3/31/2025$ -5.3M
12/31/2024$ -11.1M
9/30/2024$ -27.46M
6/30/2024$ -47.62M
3/31/2024$ -80.45M
12/31/2023$ -110.06M
9/30/2023$ -118.87M
6/30/2023$ -135.77M
3/31/2023$ -150.07M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • HERON THERAPEUTICS INC's latest trailing twelve months (TTM) EBIT stands at $ -228.7M.
  • Over the past 5 years, HERON THERAPEUTICS INC's average EBIT has been $ -145.44M.
  • The median EBIT for HERON THERAPEUTICS INC during this period was $ -165.63M
  • HERON THERAPEUTICS INC reached its highest EBIT over the past 5 years at $ 1.55M.
  • The lowest EBIT recorded by HERON THERAPEUTICS INC in the same timeframe $ -235.87M

HERON THERAPEUTICS INC's EBIT vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT Benchmarks
CompanyEBIT
GLUE : MONTE ROSA THERAPEUTICS INC $ 28.42MCHRS : COHERUS ONCOLOGY INC $ 194.89MTRDA : ENTRADA THERAPEUTICS INC $ -76.91MMGNX : MACROGENICS INC $ -34.48MVNDA : VANDA PHARMACEUTICALS INC $ -85MAGEN : AGENUS INC $ -82.97MIGMS : IGM BIOSCIENCES INC $ -53.38MOSUR : ORASURE TECHNOLOGIES INC $ -48.05MARCT : ARCTURUS THERAPEUTICS HOLDINGS INC $ -75.58MALEC : ALECTOR INC $ -115.24M

Definition of Earning Before Interest & Taxes (EBIT)

[Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].

HRTX - Earning Before Interest & Taxes (EBIT), Last 5 years

$ -235.87M

Minimum

Jun 30, 2021

$ 1.55M

Maximum

Jun 30, 2025

$ -145.44M

Average

$ -165.63M

Median

EBIT Benchmark Analysis

The chart above depicts the distribution of EBIT for companies in the Total Stock Market. The average EBIT of the companies is $ 28.62M with a standard deviation of $ 130.62M.
The following table provides additional summary stats:
EBIT in the Market:
filtered constituents3.29K
min$ -402.08M
max$ 442.4M
average$ 28.62M
median$ 897.02K
std$ 130.62M